Company: LRHC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014247
Chunk: 32

Company: La Rosa Holdings Corp.
Filing Date: 2025-02-14
Form: S-1
Chunk 32
---
 guaranteed to the Selling Stockholder the prompt and full payment and performance of the Obligations of the Company and each other Grantor.

Voting Agreement

Pursuant to the SPA, on the Closing Date the Chief Executive Officer of the Company executed a voting agreement with the Company (the “Voting Agreement”) pursuant to which the Chief Executive Officer of the Company has agreed to vote his shares of common stock in favor of stockholder resolutions providing the Stockholder Approval.

Lock-Up Agreements

Pursuant to the SPA, on the Closing Date the Chief Executive Officer of the Company and a certain institutional holder of common stock each entered into lock-up agreements (each, a “Lock-Up Agreement”), pursuant to which each signatory agreed, subject to certain customary exceptions, not to sell, offer to sell, contract or agree to sell, pledge or otherwise dispose of, directly or indirectly, shares common stock held by them for a specified period after the Closing Date.

The foregoing descriptions of the SPA, Notes, Incremental Warrants, the Security Agreement, the Lock-Up Agreements, the Voting Agreement, the Subsidiary Guaranty, and the Registration Rights Agreement is qualified in its entirety by reference to the full text of such agreements, copies of which are filed as exhibits to the registration statement of which this prospectus forms a part.

Stockholder Approval

The Company is currently listed on the Nasdaq Capital Market and is subject to the listing rules of The Nasdaq Stock Market LLC. The issuance of the Shares implicate certain of the Nasdaq listing standards requiring prior stockholder approval in order to maintain our listing on Nasdaq. On February 4, 2025, Joseph La Rosa, the Company’s Chief Executive Officer, President and Chairman, as the majority stockholder of the Company, in accordance with Nasdaq Listing Rules 5635(b) and 5635(d), approved (i) the entry into the SPA and the transactions contemplated thereunder, including the issuance of the Notes and Incremental Warrants, (ii) the issuance of shares of common stock issuable upon the full conversion of the Notes. The Company is planning to file a preliminary and definitive information statements on Schedule 14C with the SEC and mail such definitive information statement to the stockholders of records as of the close of business on February 4, 2025 notifying the stockholders of such written consent in lieu of having a stockholders’ meeting before the effectiveness of the registration statement of which this prospectus forms a part.

<div align='center'>